Literature DB >> 17651180

Acyclovir-induced neuropsychosis successfully recovered after immediate hemodialysis in an end-stage renal disease patient.

Hung-Hsu Yang1, Yu-Ping Hsiao, Hung-Chun Shih, Jen-Hung Yang.   

Abstract

A 70-year-old man developed herpes zoster over the right L5-S2 region for 3 days and was admitted for acyclovir therapy. He had a medical history of rectal cancer status post-colostomy and end-stage renal disease undergoing thrice weekly hemodialysis. Without a prior loading dose, acyclovir 500 mg (7.7 mg/kg) daily was given intravenously in two divided doses. On the third dosage, the patient became confused and agitated and developed insomnia. Within the following 24 h, delirium, visual and auditory hallucinations, disorientation to place and time, as well as impaired recent memory occurred. At the same time, a transient low grade fever (38 degrees C) was noted but resolved spontaneously after ice pillow (Fig. 1). The etiology was vigorously explored. He had no history of any neurological or psychiatric disorders. Drug history was reviewed, but no other medications besides acyclovir were currently being used. Physical examination revealed neither meningeal signs nor focal neurological deficits. Serum blood urea nitrogen, glucose, and electrolytes were within normal limits except for an elevated creatinine level at 6.2 and 5.7 mg/dl (before and after neuropsychotic symptoms, respectively). Complete blood count with differentiation was also unremarkable. Cerebrospinal fluid examination was not possible as the patient's family refused the lumbar puncture. Moreover, an electroencephalograph study and head computed tomography scan disclosed no abnormalities. Acyclovir-induced neurotoxicity was suspected. Therefore, acyclovir was discontinued. Subsequently, serum acyclovir and CMMG were checked by enzyme-linked immunosorbent assay. Serum acyclovir level was 1.6 mg/l (normal therapeutic level, 0.12-10.8 mg/l) and CMMG level was 5 mg/l. Emergent hemodialysis (4-h/session) was given; the neuropsychotic symptoms, including agitation, delirium, and visual and auditory hallucinations, greatly abated after the second session. The patient fully recovered after three consecutive days of hemodialysis; the serum was rechecked and revealed that the acyclovir level was below 0.5 mg/l and the CMMG level was undetectable. At the same time, his herpetic skin lesions resolved well.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651180     DOI: 10.1111/j.1365-4632.2007.03269.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  10 in total

1.  Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: con.

Authors:  G Chanques; S Jaber
Journal:  Intensive Care Med       Date:  2014-11-01       Impact factor: 17.440

Review 2.  Resolution of acyclovir-associated neurotoxicity with the aid of improved clearance estimates using a Bayesian approach: A case report and review of the literature.

Authors:  W A Watson; N J Rhodes; I A Echenique; M P Angarone; M H Scheetz
Journal:  J Clin Pharm Ther       Date:  2017-03-29       Impact factor: 2.512

3.  Concurrent Nephrotoxicity and Neurotoxicity Induced by Oral Valacyclovir in a Patient With Previously Normal Kidney Function.

Authors:  Ziad Abuhelwa; Azizullah Beran; Barat S Venkataramany; Bryan T Hinch; Ragheb Assaly
Journal:  Cureus       Date:  2022-03-31

4.  Herpes zoster encephalopathy or acyclovir neurotoxicity: a management dilemma.

Authors:  Daniel Sacchetti; Aydah Alawadhi; Mustafa Albakour; Alwyn Rapose
Journal:  BMJ Case Rep       Date:  2014-04-28

5.  Herpetic Keratouveitis and Trabeculectomy Failure during Infliximab Therapy in a Patient with Behçet's Disease.

Authors:  Sirel Gür Güngör; Leyla Asena; Ahmet Akman; Onur Gökmen
Journal:  Turk J Ophthalmol       Date:  2016-04-05

Review 6.  Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific.

Authors:  Liang-Kung Chen; Hidenori Arai; Liang-Yu Chen; Ming-Yueh Chou; Samsuridjal Djauzi; Birong Dong; Taro Kojima; Ki Tae Kwon; Hoe Nam Leong; Edward M F Leung; Chih-Kuang Liang; Xiaohong Liu; Dilip Mathai; Jiun Yit Pan; Li-Ning Peng; Eduardo Rommel S Poblete; Philip J H Poi; Stewart Reid; Terapong Tantawichien; Chang Won Won
Journal:  BMC Infect Dis       Date:  2017-03-15       Impact factor: 3.090

Review 7.  Acute kidney injury and acyclovir-associated encephalopathy after administration of valacyclovir in an elderly person with normal renal function: A case report and literature review.

Authors:  Tsuneaki Kenzaka; Kazuma Sugimoto; Ken Goda; Hozuka Akita
Journal:  Medicine (Baltimore)       Date:  2021-05-28       Impact factor: 1.817

8.  Rapid determination of acyclovir, its main metabolite 9-carboxymethoxymethylguanine, ganciclovir, and penciclovir in human serum using LC-MS/MS.

Authors:  Andreas Ärlemalm; Anders Helldén; Louise Karlsson; Björn Carlsson
Journal:  Biomed Chromatogr       Date:  2022-01-28       Impact factor: 1.911

9.  Disseminated cutaneous Herpes Simplex Virus-1 in a woman with rheumatoid arthritis receiving infliximab: a case report.

Authors:  Elizabeth Ann Justice; Sophia Yasmin Khan; Sarah Logan; Paresh Jobanputra
Journal:  J Med Case Rep       Date:  2008-08-26

10.  Valacyclovir Neurotoxicity and Nephrotoxicity in an Elderly Patient Complicated by Hyponatremia.

Authors:  Takuya Murakami; Tetsu Akimoto; Mari Okada; Erika Hishida; Taro Sugase; Atsushi Miki; Marina Kohara; Hiromichi Yoshizawa; Takahiro Masuda; Takahisa Kobayashi; Osamu Saito; Shigeaki Muto; Daisuke Nagata
Journal:  Drug Target Insights       Date:  2018-06-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.